Improving the identification of frail elderly newly diagnosed multiple myeloma patients
- 15 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (9), 2715-2719
- https://doi.org/10.1038/s41375-021-01162-z
Abstract
No abstract availableFunding Information
- Janssen Pharmaceuticals
- KWF Kankerbestrijding
This publication has 13 references indexed in Scilit:
- Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysisClinical Lymphoma Myeloma and Leukemia, 2019
- Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patientsLeukemia & Lymphoma, 2019
- Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancerThe Lancet Oncology, 2018
- The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based studyCancer Medicine, 2017
- Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating OutcomesClinical Lymphoma Myeloma and Leukemia, 2017
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group reportBlood, 2015
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma RegistryClinical Lymphoma Myeloma and Leukemia, 2012
- Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity scoreBlood Cancer Journal, 2011
- Chemotherapy of lung cancer in the elderlyCritical Reviews in Oncology/Hematology, 2002